{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:43:39Z","timestamp":1783781019105,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,10]]},"abstract":"<jats:p>N6-methyladenosine (m6A) RNA methylation, as a reversible epigenetic modification of mammalian mRNA, holds a critical role in multiple biological processes. m6A modification in Long non-coding RNAs (lncRNAs) has increasingly attracted more attention in recent years, especially in diabetics, with or without metabolic syndrome. We investigated via m6A-sequencing and RNA-sequencing the differentially expressed m6A modification lncRNAs by high glucose and TNF-\u03b1 induced endothelial cell dysfunction in human umbilical vein endothelial cells. Additionally, gene ontology and kyoto encyclopedia of genes and genomes analyses were performed to analyze the biological functions and pathways for the target of mRNAs. Lastly, a competing endogenous RNA network was established to further reveal a regulatory relationship between lncRNAs, miRNAs and mRNAs. A total of 754 differentially m6A-methylated lncRNAs were identified, including 168 up-regulated lncRNAs and 266 down-regulated lncRNAs. Then, 119 significantly different lncRNAs were screened out, of which 60 hypermethylated lncRNAs and 59 hypomethylated lncRNAs. Moreover, 122 differentially expressed lncRNAs were filtered, containing 14 up-regulated mRNAs and 18 down-regulated lncRNAs. Gene ontology and kyoto encyclopedia of genes and genomes analyses analyses revealed these targets were mainly associated with metabolic process, HIF-1 signaling pathway, and other biological processes. The competing endogenous RNA network revealed the regulatory relationship between lncRNAs, miRNAs and mRNAs, providing potential targets for the treatment and prevention of diabetic endothelial cell dysfunction. This comprehensive analysis for lncRNAs m6A modification in high glucose and TNF-\u03b1-induced human umbilical vein endothelial cells not only demonstrated the understanding of characteristics of endothelial cell dysfunction, but also provided the new targets for the clinical treatment of diabetes. Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences.<\/jats:p>","DOI":"10.1097\/md.0000000000033133","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T17:08:57Z","timestamp":1678468137000},"page":"e33133","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive analysis of m6A modification lncRNAs in high glucose and TNF-\u03b1 induced human umbilical vein endothelial cells"],"prefix":"10.1097","volume":"102","author":[{"given":"Li","family":"Shan","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1795-1016","authenticated-orcid":false,"given":"Mingfei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Scientific Research, The First Affiliated Hospital of Anhui Medical University, Hefei, China"},{"name":"Anhui Public Health Clinical Center, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaji","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Anhui No.2 Provincial People\u2019s Hospital, Hefei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangbing","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus.","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S2213-8587(21)00113-3","article-title":"Treatment of type 2 diabetes: challenges, hopes, and anticipated successes.","volume":"9","author":"Nauck","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e2100275","DOI":"10.1002\/advs.202100275","article-title":"Emerging targets in type 2 diabetes and diabetic complications.","volume":"8","author":"Demir","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7748\/ns.2021.e11696","article-title":"An overview of diabetic retinopathy and other ocular complications of diabetes mellitus.","volume":"36","author":"Seewoodhary","year":"2021","journal-title":"Nurs Stand"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus.","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"154838","DOI":"10.1016\/j.metabol.2021.154838","article-title":"Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.","volume":"123","author":"Yun","year":"2021","journal-title":"Metabolism"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13287-021-02687-x","article-title":"Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells.","volume":"13","author":"Su","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"109170","DOI":"10.1016\/j.diabres.2021.109170","article-title":"Irisin rescues diabetic cardiac microvascular injury via ERK1\/2\/Nrf2\/HO-1 mediated inhibition of oxidative stress.","volume":"183","author":"Zhu","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"800123","DOI":"10.3389\/fendo.2021.800123","article-title":"Identification of key LncRNAs and pathways in prediabetes and type 2 diabetes mellitus for hypertriglyceridemia patients based on weighted gene co-expression network analysis.","volume":"12","author":"Yan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1152\/physiolgenomics.00105.2021","article-title":"Integrated analysis of transcriptome profiling of lncRNAs and mRNAs in livers of type 2 diabetes mellitus.","volume":"54","author":"Lan","year":"2022","journal-title":"Physiol Genomics"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12265-021-10108-w","article-title":"N6-adenosine methylation (m6A) RNA modification: an emerging role in cardiovascular diseases.","volume":"14","author":"Chen","year":"2021","journal-title":"J Cardiovasc Transl Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.2174\/1389450121666200210125247","article-title":"N6-methyladenine RNA modification (m6A): an emerging regulator of metabolic diseases.","volume":"21","author":"Zhong","year":"2020","journal-title":"Curr Drug Targets"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.gpb.2018.03.001","article-title":"Structural insights into N6-methyladenosine (m6A) modification in the transcriptome.","volume":"16","author":"Huang","year":"2018","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.1672","article-title":"Changes in m6A RNA methylation contribute to heart failure progression by modulating translation.","volume":"22","author":"Berulava","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"119366","DOI":"10.1016\/j.lfs.2021.119366","article-title":"The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension.","volume":"274","author":"Qin","year":"2021","journal-title":"Life Sci"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12931-021-01728-6","article-title":"The role of RNA m6A methylation in the regulation of postnatal hypoxia-induced pulmonary hypertension.","volume":"22","author":"Xu","year":"2021","journal-title":"Respir Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41467-020-18957-w","article-title":"Stress-induced RNA-chromatin interactions promote endothelial dysfunction.","volume":"11","author":"Calandrelli","year":"2020","journal-title":"Nat Commun"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","article-title":"METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.","volume":"19","author":"Yang","year":"2020","journal-title":"Mol Cancer"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1111\/jcmm.15725","article-title":"Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways.","volume":"24","author":"Ren","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.biopha.2020.109825","article-title":"Carvacrol protects against diabetes-induced hypercontractility in the aorta through activation of the PI3K\/Akt pathway.","volume":"125","author":"Liu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.21037\/atm-21-4764","article-title":"Metformin alleviates bevacizumab-induced vascular endothelial injury by up-regulating GDF15 and activating the PI3K\/AKT\/FOXO\/PPAR\u03b3 signaling pathway.","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-022-03893-6","article-title":"Immune effects of PI3K\/Akt\/HIF-1\u03b1-regulated glycolysis in polymorphonuclear neutrophils during sepsis.","volume":"26","author":"Pan","year":"2022","journal-title":"Crit Care"},{"key":"R24-20250504","first-page":"1325","article-title":"LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c.","volume":"24","author":"Li","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"e11817","DOI":"10.7717\/peerj.11817","article-title":"LncRNA NEAT1 regulated diabetic retinal epithelial-mesenchymal transition through regulating miR-204\/SOX4 axis.","volume":"9","author":"Yang","year":"2021","journal-title":"PeerJ"},{"key":"R26-20250504","first-page":"1","article-title":"LncRNA XIST protects podocyte from high glucose-induced cell injury in diabetic nephropathy by sponging miR-30 and regulating AVEN expression.","volume":"17","author":"Long","year":"2020","journal-title":"Arch Physiol Biochem"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"108616","DOI":"10.1016\/j.exer.2021.108616","article-title":"The potential role of m6A RNA methylation in diabetic retinopathy.","volume":"208","author":"Kumari","year":"2021","journal-title":"Exp Eye Res"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3892\/etm.2020.9258","article-title":"lncRNA-MALAT1 expression in patients with coronary atherosclerosis and its predictive value for in-stent restenosis.","volume":"20","author":"Qiu","year":"2020","journal-title":"Exp Ther Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/db20-0375","article-title":"Long noncoding RNA MALAT1 and regulation of the antioxidant defense system in diabetic retinopathy.","volume":"70","author":"Radhakrishnan","year":"2021","journal-title":"Diabetes"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12935-020-01354-0","article-title":"LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1\/M2 polarization of Kupffer cells.","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2174\/1381612826666201029164036","article-title":"The function of LncRNA FTX in several common cancers.","volume":"27","author":"Lin","year":"2021","journal-title":"Curr Pharm Des"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10528-020-10017-8","article-title":"LncRNA FTX promotes colorectal cancer cells migration and invasion by miRNA-590-5p\/RBPJ axis.","volume":"59","author":"Chen","year":"2021","journal-title":"Biochem Genet"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yexmp.2018.12.003","article-title":"LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a\/SIRT1 axis.","volume":"107","author":"Tong","year":"2019","journal-title":"Exp Mol Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:47:07Z","timestamp":1746326827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033133","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,10]]}}}